Načítá se...

中国慢性髓性白血病患者酪氨酸激酶抑制剂治疗现状的调研:从患者的角度

OBJECTIVE: To assess tyrosine kinase inhibitor (TKI) treatment status in patients with chronic myeloid leukemia (CML) in China and analyze the response-associated factors. METHODS: From May to November in 2014, anonymous questionnaires were distributed to adult CML patients who were receiving TKI tr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Zhonghua Xue Ye Xue Za Zhi
Médium: Artigo
Jazyk:Inglês
Vydáno: Editorial office of Chinese Journal of Hematology 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7365001/
https://ncbi.nlm.nih.gov/pubmed/27535854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.07.004
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!